Oh E - Search Results

1

Two-Year Impact of Highly Effective Modulator Therapy on Olfactory Dysfunction.

Miller JE, Oh E, Khatiwada A, Humphries SM, Wilson A, Vladar EK, Lynch DA, Taylor-Cousar JL, Beswick DM. Miller JE, et al. Among authors: oh e. Laryngoscope. 2024 Jun;134(6):2492-2494. doi: 10.1002/lary.31447. Epub 2024 Apr 22. Laryngoscope. 2024. PMID: 38647113 No abstract available.

2

Parathyroid gland detection using an intraoperative autofluorescence handheld imager - early feasibility study.

Ali KM, Wolfe SA, Nagururu NV, Seo S, Han SM, Kim Y, Oh E, Kim DY, Ning B, Lee SY, Cha RJ, Tufano RP, Russell JO. Ali KM, et al. Among authors: oh e. Front Endocrinol (Lausanne). 2023 Jul 24;14:1190282. doi: 10.3389/fendo.2023.1190282. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37554762 Free PMC article.

3

Drug Use Patterns in Wastewater and Socioeconomic and Demographic Indicators.

Zhuang X, Moshi MA, Quinones O, Trenholm RA, Chang CL, Cordes D, Vanderford BJ, Vo V, Gerrity D, Oh EC. Zhuang X, et al. Among authors: oh ec. JAMA Netw Open. 2024 Sep 3;7(9):e2432682. doi: 10.1001/jamanetworkopen.2024.32682. JAMA Netw Open. 2024. PMID: 39312241

4

ChatGPT vs. sleep disorder specialist responses to common sleep queries: Ratings by experts and laypeople.

Kim J, Lee SY, Kim JH, Shin DH, Oh EH, Kim JA, Cho JW. Kim J, et al. Among authors: oh eh. Sleep Health. 2024 Sep 21:S2352-7218(24)00187-6. doi: 10.1016/j.sleh.2024.08.011. Online ahead of print. Sleep Health. 2024. PMID: 39307579

5

Oncology Dose Selection in Subsequent Indications: What Can We Learn From FDA-approved Oncology Drugs?

Ngo HX, Oh E, Li C, Yu J. Ngo HX, et al. Among authors: oh e. Clin Ther. 2024 Sep 19:S0149-2918(24)00259-5. doi: 10.1016/j.clinthera.2024.08.020. Online ahead of print. Clin Ther. 2024. PMID: 39304367 Review.

6

NADPH oxidase 1/4 dual inhibitor setanaxib suppresses platelet activation and thrombus formation.

Oh EB, Shin HJ, Yu H, Jang J, Park JW, Chang TS. Oh EB, et al. Life Sci. 2024 Sep 17;357:123061. doi: 10.1016/j.lfs.2024.123061. Online ahead of print. Life Sci. 2024. PMID: 39293714

7

An evaluation of durvalumab across the spectrum of urothelial carcinoma.

Oh EL, Redfern A, Hayne D. Oh EL, et al. Expert Rev Anticancer Ther. 2024 Sep 20:1-15. doi: 10.1080/14737140.2024.2405104. Online ahead of print. Expert Rev Anticancer Ther. 2024. PMID: 39290171 Review.

8

Diagnostic Performance of Serum Erythropoietin to Discriminate Polycythemia Vera from Secondary Erythrocytosis through Established Subnormal Limits.

Yoon JS, Kang H, Jekarl DW, Lee SE, Oh EJ. Yoon JS, et al. Among authors: oh ej. Diagnostics (Basel). 2024 Aug 29;14(17):1902. doi: 10.3390/diagnostics14171902. Diagnostics (Basel). 2024. PMID: 39272689 Free PMC article.

9

Medicare Advantage Enrollment Following the 21st Century Cures Act in Adults With End-Stage Renal Disease.

Nguyen KH, Oh EG, Meyers DJ, Rivera-Hernandez M, Kim D, Mehrotra R, Trivedi AN. Nguyen KH, et al. Among authors: oh eg. JAMA Netw Open. 2024 Sep 3;7(9):e2432772. doi: 10.1001/jamanetworkopen.2024.32772. JAMA Netw Open. 2024. PMID: 39264629 Free PMC article.

10

Perception of fecal microbiota transplantation in patients with ulcerative colitis in Korea: a KASID multicenter study.

Park J, Hong SN, Lee HS, Shin J, Oh EH, Nam K, Seong G, Kim HG, Kim JO, Jeon SR; Small Intestine Research Group and the Microbiome Research Group of the Korean Association for the Study of Intestinal Diseases (KASID). Park J, et al. Among authors: oh eh. Korean J Intern Med. 2024 Sep;39(5):783-792. doi: 10.3904/kjim.2024.053. Epub 2024 Aug 30. Korean J Intern Med. 2024. PMID: 39252488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,117 results

Search Page